Literature DB >> 6766067

Studies on the lysyl hydroxylase reaction. II. Inhibition kinetics and the reaction mechanism.

U Puistola, T M Turpeenniemi-Hujanen, R Myllylä, K I Kivirikko.   

Abstract

Product inhibition of lysyl hydroxylase (peptidyllysine, 2-oxoglutarate:oxygen 5-oxidoreductase, EC 1.14.11.4) was studied with succinate, CO2, dehydroascorbate and hydroxylysine-rich polypeptide chains. The product inhibition patterns and addition data are consistent with a reaction mechanism involving an ordered binding of Fe2+, alpha-ketoglutarate, O2 and the peptide substrate to the enzyme in this order, and an ordered release of the hydroxylated peptide, CO2, succinate and Fe2+, in which Fe2+ need not leave the enzyme during each catalytic cycle and in which the order of release of the hydroxylated peptide and CO2 is uncertain. Ascorbate probably reacts by a substitution mechanism, either after the release of the hydroxylated peptide, CO2 and succinate or after the release of all products, including Fe2+, and dehydroascorbate is released before the binding of Fe2+. It is suggested that the ascorbate reaction is required to reduce either the enzyme-iron complex or the free enzyme, which may be oxidized by a side-reaction during some catalytic cycles, but not the majority. The mechanisms of the prolyl 4-hydroxylase and lysyl hydroxylase reactions are suggested to be identical. Zn2+, several citric acid cycle intermediates, nitroblue tetrazolium and homogentisic acid inhibited lysyl hydroxylase competitively with regard to Fe2+, alpha-ketoglutarate, O2 and ascorbate respectively, and epinephrine non-competitively with regard to all cosubstrates. Apparent Ki values are given for the product and other inhibitors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766067     DOI: 10.1016/0005-2744(80)90041-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen.

Authors:  C J Pruchno; D H Cohn; G A Wallis; M C Willing; B J Starman; X M Zhang; P H Byers
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

2.  The catalytic mechanism of the hydroxylation reaction of peptidyl proline and lysine does not require protein disulphide-isomerase activity.

Authors:  R Myllylä; D D Kaska; K I Kivirikko
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  A scalable lysyl hydroxylase 2 expression system and luciferase-based enzymatic activity assay.

Authors:  Hou-Fu Guo; Eun Jeong Cho; Ashwini K Devkota; Yulong Chen; William Russell; George N Phillips; Mitsuo Yamauchi; Kevin N Dalby; Jonathan M Kurie
Journal:  Arch Biochem Biophys       Date:  2017-02-20       Impact factor: 4.013

4.  Immunological characterization of lysyl hydroxylase, an enzyme of collagen synthesis.

Authors:  T M Turpeenniemi-Hujanen
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

5.  The source of oxygen in the reaction catalysed by collagen lysyl hydroxylase.

Authors:  Y Kikuchi; Y Suzuki; N Tamiya
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

6.  Isolation of lysyl hydroxylase, an enzyme of collagen synthesis, from chick embryos as a homogeneous protein.

Authors:  T M Turpeenniemi-Hujanen; U Puistola; K I Kivirikko
Journal:  Biochem J       Date:  1980-08-01       Impact factor: 3.857

7.  Steady-state kinetic studies of the inhibitory action of Zn2+ on ribonuclease T1 catalysis.

Authors:  M Itaya; Y Inoue
Journal:  Biochem J       Date:  1982-11-01       Impact factor: 3.857

Review 8.  Metabolism and epigenetics.

Authors:  Ryan Janke; Anne E Dodson; Jasper Rine
Journal:  Annu Rev Cell Dev Biol       Date:  2015-09-10       Impact factor: 13.827

9.  Polyclonal and monoclonal antibodies to human lysyl hydroxylase and studies on the molecular heterogeneity of the enzyme.

Authors:  R Myllylä; L Pajunen; K I Kivirikko
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

10.  Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome--an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13.

Authors:  Cecilia Giunta; Nursel H Elçioglu; Beate Albrecht; Georg Eich; Céline Chambaz; Andreas R Janecke; Heather Yeowell; MaryAnn Weis; David R Eyre; Marius Kraenzlin; Beat Steinmann
Journal:  Am J Hum Genet       Date:  2008-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.